Interview: Philip Lewis Williams – Managing Director, Théa Pharmaceuticals, UK

Philip Lews Williams, managing director of the UK affiliate of French ophthalmology specialist Théa, describes the evolution of the company’s engagement in the UK and his strategy for taking on the big players in eyecare. Laboratoires Théa entered the UK for the first time back in 2007 via a joint venture with Macclesfield-based outfit, Spectrum. How would you describe the evolution of the company’s engagement with the British market?
"As a mid-cap, family owned and run entity that is endowed with a very strong sense of company culture and mission, we found we were able to bring a certain style of etiquette more akin to the world of old pharma. "
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report